OpenAlex
Journal for ImmunoTherapy of Cancer
Source
View works
ISSN 2051-1426
Source type: journal
Publisher: BMJ
Alternate name JITC
Fully open access: Yes
In DOAJ: Yes
Article Processing Charge: $2,600
2yr mean citedness: 9.902
H-index: 153
I10-index: 2,490
Works count: 5,732
Citations count: 144,300
Top works
Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group
2017 · Igor Puzanov, Adi Diab, et al. · Journal for ImmunoTherapy of Cancer
Cytokine release syndrome
2018 · Alexander Shimabukuro‐Vornhagen, Philipp Gödel, et al. · Journal for ImmunoTherapy of Cancer
Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations
2018 · Jun Gong, Alex Chehrazi‐Raffle, et al. · Journal for ImmunoTherapy of Cancer
Key stats
year
open access
topic
type